Gastrointestinal stromal tumors (GIST).: Surgical therapy

被引:7
作者
Wente, M. N. [1 ]
Buechler, M. W. [1 ]
Weitz, J. [1 ]
机构
[1] Univ Klinikum Heidelberg, Klin Allgemein Viszeral & Transplantat Chirurg, D-69120 Heidelberg, Germany
来源
CHIRURG | 2008年 / 79卷 / 07期
关键词
gastrointestinal stromal tumors; GIST; sarcoma; surgical therapy; localization;
D O I
10.1007/s00104-008-1527-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal neoplasms of the gastrointestinal tract. GIST occur predominantly in the stomach and less frequently in the extraduodenal small bowel, the colon, and the rectum; rarely, GIST can be found in the esophagus and the duodenum. Due to their biological behavior, the primary treatment goal for localized primary GIST is complete resection, without the need for lymphadenectomy or wide resection margins. Thus, gastric wedge resections and segmental resections of the small bowel are the most common surgical procedures for treating primary GIST. Surgical therapy of extensive primary tumors or of metastatic or recurrent GIST should be integrated into a multimodal therapeutic concept that includes targeted therapy with tyrosine kinase inhibitors, such as imatinib.
引用
收藏
页码:638 / 643
页数:6
相关论文
共 50 条
  • [31] Gastrointestinal stromal tumors (GIST): Role of the surgeon in the molecular medicine era
    Toro Vasquez, Juan Pablo
    Madrid Velez, Jorge Alberto
    IATREIA, 2010, 23 (03) : 268 - 277
  • [32] Adjuvant therapy of gastrointestinal stromal tumors
    Koshenkov, Vadim P.
    Rodgers, Steven E.
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (04) : 414 - 418
  • [33] An update of the surgical indications for gastrointestinal stromal tumors
    Bonvalot, S.
    JOURNAL DE CHIRURGIE, 2008, 145 : S8 - S11
  • [34] Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors
    Sicklick, Jason K.
    Lopez, Nicole E.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (11) : 1997 - 2006
  • [35] Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors
    Jason K. Sicklick
    Nicole E. Lopez
    Journal of Gastrointestinal Surgery, 2013, 17 : 1997 - 2006
  • [36] Neoadjuvant Imatinib in Gastrointestinal Stromal Tumors (GIST): The First Analysis of a Mexican Population
    Guzman, Rafael Medrano
    Lara, Xavier Lopez
    Rivera, Atl Simon Arias
    Rios, Luis. E. Garcia
    Chaoul, Moises Brener
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [37] The GIST of it all: management of gastrointestinal stromal tumors (GIST) from the first steps to tailored therapy. A bibliometric analysis
    Julian Musa
    Sarah M. Kochendoerfer
    Franziska Willis
    Christine Sauerteig
    Jonathan M. Harnoss
    Ingmar F. Rompen
    Thomas G. P. Grünewald
    Mohammed Al-Saeedi
    Martin Schneider
    Julian-C. Harnoss
    Langenbeck's Archives of Surgery, 409
  • [38] The GIST of it all: management of gastrointestinal stromal tumors (GIST) from the first steps to tailored therapy. A bibliometric analysis
    Musa, Julian
    Kochendoerfer, Sarah M.
    Willis, Franziska
    Sauerteig, Christine
    Harnoss, Jonathan M.
    Rompen, Ingmar F.
    Gruenewald, Thomas G. P.
    Al-Saeedi, Mohammed
    Schneider, Martin
    Harnoss, Julian-C.
    LANGENBECKS ARCHIVES OF SURGERY, 2024, 409 (01)
  • [39] Targeted therapies of gastrointestinal stromal tumors (GIST)-The next frontiers
    Duensing, Stefan
    Duensing, Anette
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (05) : 575 - 583
  • [40] Ripretinib in the treatment of patients with advanced gastrointestinal stromal tumors (GIST)
    Babula, Emilia
    Sikora, Aleksandra
    Sobczuk, Pawel
    Rutkowski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (01): : 40 - 51